Madrigal Pharmaceuticals Inc (MDGL)

313.11 -0.93 (-0.30%) USD  |  NASDAQ  |  Dec 27, 16:00
313.64 +0.53 (+0.17%) Pre-Market: 20:00
More

Madrigal Pharmaceuticals EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Earnings Per Share Estimates Definition

View Earnings Per Share Estimates Definition
Start Trial

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

View EPS Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Quarter Benchmarks

View EPS Estimates for Current Quarter Benchmarks
Start Trial
Corcept Therapeutics Inc Upgrade
89bio Inc Upgrade
ADMA Biologics Inc Upgrade
Matinas BioPharma Holdings Inc Upgrade
Viking Therapeutics Inc Upgrade

EPS Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade